Novel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Scientists create online database to aid CML researchApril 28, 2017Leukemia, Myelodysplasia, TransplantationCML
Proteins may be therapeutic targets for TKI-resistant CML, ALLMarch 21, 2017Leukemia, Myelodysplasia, TransplantationALLCML
Imatinib is safe, effective long-term, team saysMarch 10, 2017Leukemia, Myelodysplasia, TransplantationCML
Acquired mutations may compromise assayFebruary 28, 2017Leukemia, Myelodysplasia, TransplantationALLCML
Group ranks TKIs according to cardiotoxicityFebruary 17, 2017Leukemia, Myelodysplasia, TransplantationPharmacyRelated IssuesALLCML
Styrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
Study quantifies 5-year survival rates for blood cancersJanuary 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Drugs may be effective against hematologic, other cancersJanuary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLCMLAggressive Lymphomas
Study reveals CML patients likely to benefit from HSCT long-termDecember 15, 2016Leukemia, Myelodysplasia, TransplantationTransplantationCML
Group estimates global cancer cases, deaths in 2015December 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLALLHodgkin Lymphoma
Half of CML patients can stop TKI therapy, study suggestsDecember 7, 2016Leukemia, Myelodysplasia, TransplantationCML
FDA grants full approval for ponatinibNovember 30, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Compound could treat a range of blood cancersOctober 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin Lymphoma